(Q43660233)

English

Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in unresectable and locally advanced non-small cell lung cancer

scientific article published in July 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in unresectable and locally advanced non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

inferred from title

author name string

M Oka

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

M Fukuda

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

M Fukuda

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

A Kinoshita

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

M Kuba

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

M Ichiki

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

T Rikimaru

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

H Soda

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

H Takatani

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

F Narasaki

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

S Nagashima

11

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Y Nakamura

12

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

N Hayashi

13

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

S Kohno

14

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1359-1365

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of docetaxel with concomitant thoracic radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan (CPT-11): pharmacology and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of tumor radio-response by irinotecan in human lung tumor xenografts.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-finding study of irinotecan and cisplatin plus concurrent radiotherapy for unresectable stage III non-small-cell lung cancer [seecomments].

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors of pneumonitis following chemoradiotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternating chemotherapy and accelerated split-course irradiation in locally advanced nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(01)00099-5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43660233&oldid=2102369056"